Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03708328
Title A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Columbia Univ Med Ctr New York New York 10032 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Herlev Hospital; Afdeling for Kræftbehandling Herlev 2730 Denmark Details
Rigshospitalet; Onkologisk Klinik København Ø 2100 Denmark Details
Institut Bergonie; Oncologie Bordeaux 33076 France Details
Centre Leon Berard; Service Oncologie Medicale Lyon 69008 France Details
CHU Timone; Centre d'Essais Précoces en Cancérologie de Marseille (CEPCM) Marseille 13005 France Details
ICO Rene Gauducheau; CEC St Herblain 44805 France Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul 03722 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
Auckland City Hospital; Clinical Oncology Auckland 1023 New Zealand Details
Clinica Universitaria de Navarra; Servicio de oncología Pamplona Navarra 31008 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Hospital Ramon y Cajal; Servicio de Oncologia Madrid 28034 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
Hospital Clínico Universitario de Valencia; Servicio de Oncología Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from for the field